C A Staton

723 total citations
14 papers, 598 citations indexed

About

C A Staton is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, C A Staton has authored 14 papers receiving a total of 598 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in C A Staton's work include Angiogenesis and VEGF in Cancer (9 papers), Cell Adhesion Molecules Research (3 papers) and Blood properties and coagulation (2 papers). C A Staton is often cited by papers focused on Angiogenesis and VEGF in Cancer (9 papers), Cell Adhesion Molecules Research (3 papers) and Blood properties and coagulation (2 papers). C A Staton collaborates with scholars based in United Kingdom, Switzerland and Norway. C A Staton's co-authors include Nicola J. Brown, Malcolm Reed, Simon S. Cross, Iain Cameron, Sabapathy P. Balasubramanian, S.E. Higham, Manoj K. Valluru, Claire E. Lewis, James Underwood and Kevin P. Corke and has published in prestigious journals such as Gut, British Journal of Cancer and British journal of surgery.

In The Last Decade

C A Staton

14 papers receiving 587 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C A Staton United Kingdom	10	341	191	143	96	72	14	598
Erin M. Conn United States	6	399 1.2×	120 0.6×	121 0.8×	34 0.4×	46 0.6×	6	649
K Rubin Sweden	8	380 1.1×	158 0.8×	86 0.6×	57 0.6×	63 0.9×	8	850
Karyn Bouhana United States	13	560 1.6×	192 1.0×	295 2.1×	55 0.6×	71 1.0×	26	946
Harri Elamaa Finland	13	484 1.4×	122 0.6×	126 0.9×	53 0.6×	37 0.5×	18	819
Ylva Paulsson Sweden	14	501 1.5×	170 0.9×	105 0.7×	39 0.4×	82 1.1×	17	803
Michelle E. Lewallen United States	7	347 1.0×	174 0.9×	151 1.1×	47 0.5×	35 0.5×	8	543
Adeline Tucker United States	8	515 1.5×	88 0.5×	187 1.3×	39 0.4×	35 0.5×	9	780
Yatin Patel United Kingdom	13	495 1.5×	129 0.7×	161 1.1×	56 0.6×	60 0.8×	23	981
Jacob Farnebo Sweden	5	644 1.9×	379 2.0×	189 1.3×	52 0.5×	60 0.8×	8	872

Countries citing papers authored by C A Staton

Since Specialization

Citations

This map shows the geographic impact of C A Staton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C A Staton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C A Staton more than expected).

Fields of papers citing papers by C A Staton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C A Staton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C A Staton. The network helps show where C A Staton may publish in the future.

Co-authorship network of co-authors of C A Staton

This figure shows the co-authorship network connecting the top 25 collaborators of C A Staton. A scholar is included among the top collaborators of C A Staton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C A Staton. C A Staton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Young, Robin, Penella J. Woll, C A Staton, Malcolm Reed, & Nicola J. Brown. (2013). Vascular-targeted agents for the treatment of angiosarcoma. Cancer Chemotherapy and Pharmacology. 73(2). 259–270. 16 indexed citations

Amarzguioui, M., et al.. (2010). Anti-tissue factor short hairpin RNA inhibits breast cancer growth in vivo. Breast Cancer Research and Treatment. 128(3). 691–701. 9 indexed citations

Lewis, Claire E., et al.. (2010). A novel fragment derived from the β chain of human fibrinogen, β43–63, is a potent inhibitor of activated endothelial cells in vitro and in vivo. British Journal of Cancer. 102(3). 594–601. 13 indexed citations

Staton, C A, et al.. (2010). Angiopoietin-1, angiopoietin-2 and Tie-2 receptor expression in human dermal wound repair and scarring. British Journal of Dermatology. 163(5). 920–927. 50 indexed citations

Cross, Simon S., S.E. Higham, Sabapathy P. Balasubramanian, et al.. (2009). Angiogenesis is associated with the onset of hyperplasia in human ductal breast disease. British Journal of Cancer. 101(4). 666–672. 79 indexed citations

Staton, C A, et al.. (2009). Angiogenesis, vascular endothelial growth factor and its receptors in human surgical wounds. British journal of surgery. 96(12). 1484–1491. 73 indexed citations

Brown, Nicola J., et al.. (2008). Angiogenesis in pre-malignant conditions. British Journal of Cancer. 99(12). 1961–1966. 57 indexed citations

Cross, Simon S., et al.. (2008). Assessment of angiogenesis in the hyperplasia preinvasive, invasive breast carcinoma sequence. Breast Cancer Research. 10(S2). 2 indexed citations

Staton, C A, Zhiyong Yang, Malcolm Reed, & Nicola J. Brown. (2008). Bevacizumab resistance in breast cancer: are neuropilins the key?. Breast Cancer Research. 10(S2). 4 indexed citations

10.

Staton, C A, Stephen M. Stribbling, Carlos Garcı́a-Echeverrı́a, et al.. (2007). Identification of key residues involved in mediating the in vivo anti‐tumor/anti‐endothelial activity of Alphastatin. Journal of Thrombosis and Haemostasis. 5(4). 846–854. 12 indexed citations

11.

Staton, C A, et al.. (2007). The angiogenic switch occurs at the adenoma stage of the adenoma carcinoma sequence in colorectal cancer. Gut. 56(10). 1426–1432. 74 indexed citations

12.

Staton, C A, et al.. (2007). Neuropilins in physiological and pathological angiogenesis. The Journal of Pathology. 212(3). 237–248. 186 indexed citations

13.

Staton, C A, Nicola J. Brown, Kevin P. Corke, et al.. (2004). OC9 ALPHASTATIN, A 24-AMINO ACID FRAGMENT OF FIBRINOGEN IS A NOVEL ANTI-ANGIOGENIC AND ANTI-VASCULAR AGENT. Microcirculation. 11(6). 531–532. 1 indexed citations

14.

Brown, Nicola J., et al.. (2002). Fibrinogen E fragment selectively disrupts the vasculature and inhibits the growth of tumours in a syngeneic murine model. British Journal of Cancer. 86(11). 1813–1816. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact